W D Dupont

发表

Rejoinder: statistical inference from trials with sequential stopping rules.

W D Dupont, W. Dupont, 1983, Controlled clinical trials.

Making causal inferences from observational data.

W D Dupont, 1978, Biometrics.

Risk factors for breast cancer in women with proliferative breast disease.

W D Dupont, W. Dupont, D. Page, 1985, The New England journal of medicine.

Histologic grading of breast carcinoma. A reproducibility study

W D Dupont, L W Dalton, W. Dupont, 1994, Cancer.

A stochastic catch-effort method for estimating animal abundance.

W D Dupont, W. Dupont, 1983, Biometrics.

Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading

W D Dupont, W. Dupont, F. Parl, 1984, Cancer.

Understanding the relationship between relative and absolute risk

W D Plummer, W D Dupont, W. Dupont, 1996, Cancer.

Power calculations for matched case-control studies.

W D Dupont, W. Dupont, 1988, Biometrics.

Long-term risk of breast cancer in women with fibroadenoma.

W D Plummer, W D Dupont, W. Dupont, 1994, The New England journal of medicine.

Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.

W D Dupont, W. Dupont, F. Parl, 1992, Cancer research.

Prognostic value of morphometry in patients with normal breast tissue or usual ductal hyperplasia of the breast

W D Dupont, P. V. van Diest, P. V. van Diest, 2001, International journal of cancer.

Power and sample size calculations for studies involving linear regression.

W D Plummer, W D Dupont, W. Dupont, 1998, Controlled clinical trials.